Apple Tree Partners

Company

Investment-firm

Last deal

$5M

Amount

Undisclosed

Stage

22.12.2021

Date

1

all rounds

$5M

Total amount

Financing round

General

About Company
Apple Tree Partners is a life sciences venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Industry

Sector :

Subsector :

Keywords :

Also Known As

ATP Life Sciences Ventures

founded date

01.01.1999

Number of employees

Last funding type

Undisclosed

IPO status

Private

Description

The firm creates science-based companies starting with assets at various stages, investing in them from seed stage through IPO and beyond, providing flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises that improve human lives.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Pontifax

Pontifax

Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Herzliya, Israel

count Of Investments

97

count Of Exists

9
Quaker BioVentures

Quaker BioVentures

Quaker BioVentures is a venture capital firm investing in life science companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Philadelphia, PA, USA

count Of Investments

43

count Of Exists

15
Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund is a private equity and venture capital arm of Novartis AG.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Basel, Switzerland

count Of Investments

201

count Of Exists

39
BioMedPartners

BioMedPartners

BioMedPartners is a leading European venture capital firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Venture Capital, Financial Services

Location

Basel, Switzerland

count Of Investments

67

count Of Exists

12

Financials

Funding Rounds
1
1

Number of Funding Rounds

$5M

Money Raised

Their latest funding was raised on 22.12.2021. Their latest round Undisclosed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
22.12.2021
$5M
Investments
55
Date 
name 
Lead 
type 
Raised 
Deep Apple Therapeutics

Deep Apple Therapeutics

Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.

total rounds

1

total raised

$52M
Ascidian Therapeutics

Ascidian Therapeutics

Ascidian Therapeutics redefines disease treatment by rewriting RNA.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boston, MA, USA

total rounds

3

total raised

$90M
Aulos Bioscience

Aulos Bioscience

Aulos Bioscience develops cancer treatments using immuno-oncology therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Cambridge, MA, USA

total rounds

2

total raised

$60M
Co-Investors
Exits
7
Dermira

Dermira

Dermira is a specialty biopharmaceutical company that develops innovative products for dermatologists and their patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Menlo Park, CA, USA

total rounds

13

total raised

$1.13B
Cyrano Sciences

Cyrano Sciences

Cyrano Sciences provides chemical and biological sensors and software solutions.

Sector

Electronic and Electrical Equipment

Subsector

Gauges and Meters

Keywords

Electronics, Manufacturing, Biotechnology

Location

Pasadena, CA, USA

total rounds

2

total raised

$23M
Limelight Bio

Limelight Bio

Limelight Bio is developing novel gene therapies to treat debilitating inherited diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Philadelphia, PA, USA

total rounds

2

total raised

$89M

People

Founders
1
Seth Harrison
Seth Harrison

Seth Harrison

Seth Harrison is the managing partner of Apple Tree Partners and serves as Executive Chairman of Braeburn Pharmaceuticals. He has invested in life sciences since 1991. Seth has served as founding investor, acting CEO or chairman of numerous portfolio companies. He is currently also Chairman of Tokai Pharmaceuticals, Chairman of Aileron Therapeutics and Deputy Chairman of Heartware International, all companies he founded. Prior to founding ATP, Seth was a general partner at Oak Investment Partners and earlier was a venture partner at Sevin Rosen Funds. His prior investments include: ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, Informed Access, SGX Pharmaceuticals, Ultracision and ViroPharma. Seth received an A.B. from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at the Presbyterian Hospital in the City of New York. From 2002 – 2010 he served on the board of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation sponsored public-private partnership engaged in the development of anti-HIV microbicides.

current job

Oak Investment Partners
Oak Investment Partners

Seth Harrison

Employee Profiles
43
Mohit Trikha

Mohit Trikha

Venture Partner

Raúl Saraiva

Raúl Saraiva

Associate

Phil Patten

Phil Patten

Entrepreneur in Residence

Alexander McCampbell

Alexander McCampbell

Venture Partner

Anna Batarina

Anna Batarina

Partner

Paul R. Eisenberg

Paul R. Eisenberg

Venture Partner

Michael Ehlers

Michael Ehlers

Chief Scientific Officer and Venture Partner

Jonathan Young

Jonathan Young

Venture Partner

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month